Pharma MSMEs seek government intervention to tackle shortage, price increase of raw materials Read more
DoP organises meeting with industry associations to discuss implementation of Phase II PLI scheme Read more
To accelerate recovery of pharma ancillary industry, primary focus should be financial relief to players Read more
